HCV therapy and risk of liver cancer recurrence: who to treat?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Link
http://www.nature.com/articles/s41575-018-0018-5.pdf
Reference10 articles.
1. Backus, L. I. et al. Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease. Hepatology https://doi.org/10.1002/hep.29408 (2017).
2. Backus, L. I. et al. Direct-acting antiviral sustained virologic response: impact on mortality in patients without advanced liver disease. Hepatology https://doi.org/10.1002/hep.29811 (2018).
3. Huang, A. C. et al. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout. Hepatology https://doi.org/10.1002/hep.29855 (2018).
4. Roche, B. et al. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Liver Int. 38 (Suppl. 1), 139–145.
5. Terrault, N. A. et al. International liver transplantation society consensus statement on hepatitis c management in liver transplant candidates. Transplantation 101, 945–955 (2017).
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease;European Journal of Cancer Prevention;2024-03-22
2. Rapid Visual Detection of Hepatitis C Virus Using Reverse Transcription Recombinase-Aided Amplification–Lateral Flow Dipstick;Frontiers in Cellular and Infection Microbiology;2022-02-17
3. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma;Cells;2021-11-09
4. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients;United European Gastroenterology Journal;2021-02-18
5. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis;Journal of Hepatology;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3